The New South Wales (NSW) Government announced a $160 million medical research initiative, signalling a quest for advancements in healthcare.
Entering its fourth instalment, the Medical Research Support Program (MRSP) aims to bolster excellence in health and medical research by financing indirect research costs, such as equipment and support staff, the government said in a news release.
Applications for this program, overseen by the Office of Health and Medical Research, will commence today, 13 May.
Among the esteemed beneficiaries of past rounds are the Black Dog Institute, Garvan Institute of Medical Research, Ingham Institute for Applied Medical Research, and the Woolcock Institute.
According to the government, funding from preceding MRSP rounds has significantly contributed to NSW’s status as a leader in research achievements globally.
This includes landmark achievements such as Australia’s inaugural precision medicine program for pediatric cancer, the creation of a unified test for over 50 genetic conditions, and the development of personalized digital mental health tools catering to individuals grappling with depression, anxiety, and stress.
Prospective applicants can access MRSP application guidelines and program specifics online or by contacting the Office for Health and Medical Research at MOH-OHMRGrants@health.nsw.gov.au.
Minister for Medical Research David Harris expressed his support, stating, “We are proud to support the world-class health and medical research taking place right here in NSW through the Medical Research Support Program.”
He added, “This funding is vital as it covers some of the costs that independent medical research institutes must pay, but may not be included in awarded research grants, such as the costs of infrastructure and support staff.”
He also expressed optimism about the investment in such programs, foreseeing improved health outcomes as a result.
“I look forward to seeing the incredible research made possible by this round of MRSP funding in the years to come,” Harris concluded.